Transplatin
Chemical compound
| Chemical Compound | |
|---|---|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider ID | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| Properties | |
| Chemical Formula | |
| Molar Mass | |
| Appearance | |
| Density | |
| Melting Point | |
| Boiling Point | |
| Hazards | |
| GHS Pictograms | [[File:|50px]] |
| GHS Signal Word | |
| GHS Hazard Statements | |
| NFPA 704 | [[File:|50px]] |
| References | |
Transplatin, or trans-dichlorodiammineplatinum(II), is a chemical compound with the formula trans-[PtCl2(NH3)2]. It is an isomer of the more well-known cisplatin, which is used as a chemotherapy drug. Unlike cisplatin, transplatin is not effective as an anticancer agent.
Structure and properties
Transplatin is a coordination complex of platinum with two chloride ions and two ammonia molecules. The compound is characterized by its trans configuration, meaning that the two chloride ions are opposite each other in the molecular structure. This configuration is in contrast to the cis configuration found in cisplatin, where the chloride ions are adjacent.
The trans configuration of transplatin affects its chemical reactivity and biological activity. The compound is less able to form cross-links with DNA, which is a key mechanism by which cisplatin exerts its anticancer effects. As a result, transplatin does not have the same therapeutic properties as cisplatin.
Synthesis
Transplatin can be synthesized by the reaction of potassium tetrachloroplatinate(II) with ammonia in the presence of a chloride source. The reaction typically involves the formation of an intermediate complex, which rearranges to form the trans isomer. The synthesis of transplatin is often carried out in an aqueous solution, and the product can be isolated by crystallization.
Applications
While transplatin itself is not used as a drug, it serves as a useful compound in the study of platinum-based chemotherapy agents. Researchers have investigated various derivatives of transplatin in an effort to develop new anticancer drugs with improved properties. Some of these derivatives have shown promise in preclinical studies.
Related compounds
References
- ,
Platinum compounds: a new class of potent antitumour agents, Nature, 1969, Vol. 222(Issue: 5191), pp. 385–386, DOI: 10.1038/222385a0,
- B. K.,
Metal Complexes in Cancer Chemotherapy, VCH, 1993, ISBN 978-3-527-28302-4,
Related pages
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian